Mauna Kea Technologies SA (LON:0P5I)
0.183
+0.003 (1.66%)
At close: Feb 19, 2025
Mauna Kea Technologies Company Description
Mauna Kea Technologies SA, a medical device company, manufactures and sells medical devices in Europe and internationally.
It offers range of medical devices in gastroenterology, pulmonology, and urology areas. Its product portfolio includes Cellvizio, a real-time in vivo cellular imaging platform which enables physicians to monitor progression of disease over time, assess point-in-time reactions, classify indeterminate areas, and guide surgical interventions.
The company was incorporated in 2000 and is headquartered in Paris, France.
Mauna Kea Technologies SA
Country | France |
Founded | 2000 |
Industry | Electromedical and Electrotherapeutic Apparatus |
Employees | 68 |
CEO | Alexandre Loiseau |
Contact Details
Address: 9, rue d'Enghien Paris, 75010 France | |
Phone | 33 1 48 24 03 45 |
Website | maunakeatech.com |
Stock Details
Ticker Symbol | 0P5I |
Exchange | London Stock Exchange |
Fiscal Year | January - December |
Reporting Currency | EUR |
SIC Code | 3845 |
Key Executives
Name | Position |
---|---|
Alexandre Loiseau | Chief Executive Officer |
Come de La Tour du Pin | Chief Financial Officer |
Nathalie Lecoq | Chief Operating Officer |